
AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Herc, you need to believe that integration of the H&E acquisition, steady infrastructure demand and better margins can outweigh high leverage and uneven profitability. The latest AI-driven capex enthusiasm, which helped lift the shares, does not materially change the near term focus on integration execution and debt risk, but it does highlight how quickly sentiment can swing around perceived long term demand for equipment.
The most relevant recent announcement here is Herc’s first quarter 2026 result, which showed strong revenue of US$1,139 million but a net loss of US$24 million. That mix of top line growth and bottom line pressure frames the AI-related optimism: higher demand could help utilization, but the real catalyst remains whether management can turn that larger revenue base into sustainable profits while working through H&E integration and a heavy interest burden.
Yet, against this optimism, investors should be aware of how Herc’s elevated debt and interest costs could limit its ability to...
Read the full narrative on Herc Holdings (it's free!)
Herc Holdings' narrative projects $5.8 billion revenue and $553.2 million earnings by 2029.
Uncover how Herc Holdings' forecasts yield a $168.90 fair value, a 13% upside to its current price.
While recent AI capex enthusiasm has supported the share price, the most pessimistic analysts were previously assuming about US$5.6 billion of 2028 revenue and US$703.7 million of earnings, yet still saw environmental and digital disruption as powerful headwinds, reminding you that views on Herc’s future can differ widely and may shift again as this new information is digested.
Explore 2 other fair value estimates on Herc Holdings - why the stock might be worth as much as 63% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com